Flashpoint Therapeutics, Inc.
Palo Alto, CA
- UEI
- T1E5JPJQ9YQ6
- CAGE
- 9WRE6
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 4145 Amaranta Ave, Palo Alto, CA 94306, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| LNP-based snas to overcome immunosuppression in glioblastoma | Defense Health Agency | $373,470 |
Quick answers
What is Flashpoint Therapeutics, Inc.'s UEI?
Flashpoint Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is T1E5JPJQ9YQ6.
What is Flashpoint Therapeutics, Inc.'s CAGE code?
Flashpoint Therapeutics, Inc.'s CAGE code is 9WRE6.
What is Flashpoint Therapeutics, Inc.'s primary NAICS code?
Flashpoint Therapeutics, Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).
Where is Flashpoint Therapeutics, Inc. located?
Flashpoint Therapeutics, Inc.'s physical address in SAM.gov is 4145 Amaranta Ave, Palo Alto, CA 94306, USA.
Is Flashpoint Therapeutics, Inc. registered in SAM.gov?
Yes. Flashpoint Therapeutics, Inc.'s SAM.gov registration is active through April 16, 2027.
What is Flashpoint Therapeutics, Inc.'s most recent federal award?
Flashpoint Therapeutics, Inc.'s most recent federal grant award is LNP-based snas to overcome immunosuppression in glioblastoma (HT94252510868), from Defense Health Agency, on September 1, 2025.
On GovTribe
See Flashpoint Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors